Clinical Medicine Section of Department of Internal Medicine, Federal University of São Paulo/Paulista School of Medicine, São Paulo, Brazil.
J Bras Pneumol. 2010 Sep-Oct;36(5):626-40. doi: 10.1590/s1806-37132010000500016.
The main objectives of tuberculosis therapy are to cure the patients and to minimize the possibility of transmission of the bacillus to healthy subjects. Adverse effects of antituberculosis drugs or drug interactions (among antituberculosis drugs or between antituberculosis drugs and other drugs) can make it necessary to modify or discontinue treatment. We briefly review the new guidelines for the pharmacological treatment of tuberculosis, introduced by the Brazilian National Ministry of Health in 2009, and describe the general mechanism of action, absorption, metabolization, and excretion of the first-line drugs used in the basic regimen. We describe adverse drug reactions and interactions (with other drugs, food, and antacids), as well as the most appropriate approach to special situations, such as pregnancy, breastfeeding, liver failure, and kidney failure. We also describe the mechanisms by which the interactions among the antituberculosis drugs used in the basic regimen can cause drug-induced hepatitis, and we discuss the alternatives in this situation.
结核病治疗的主要目标是治愈患者,并最大程度降低将结核菌传播给健康人群的可能性。抗结核药物的不良反应或药物相互作用(抗结核药物之间或抗结核药物与其他药物之间)可能需要调整或停止治疗。我们简要回顾了 2009 年巴西国家卫生部发布的结核病药理学治疗新指南,并描述了基本方案中一线药物的一般作用机制、吸收、代谢和排泄。我们描述了药物不良反应和相互作用(与其他药物、食物和抗酸剂),以及特殊情况下(如妊娠、哺乳、肝衰竭和肾衰竭)的最佳处理方法。我们还描述了基本方案中抗结核药物相互作用引起药物性肝炎的机制,并讨论了这种情况下的替代方案。